跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-1
首页
药物
R-1
R-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
US 7122536 B2
申请人: PFIZER
优先权: 2001
US
19 件公开
Salt forms of [R-(R*,R*)]-2-(4-fluorophenyl)-, -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)Carbonyl]-1H-pyrrole-1-heptanoic acid
US 7875731 B2
申请人: PFIZER
优先权: 2005
EP
US
17 件公开
Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one
US 2002028949 A1
申请人: FRUTOS ROGELIO P
优先权: 2001
US
10 件公开
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-,-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1)
US 8026376 B2
申请人: PFIZER
优先权: 2005
US
10 件公开
2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1
US 2009099245 A1
申请人: ABBOTT LAB
优先权: 2007
CN
US
9 件公开
Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
US 7144915 B2
申请人: WARNER LAMBERT CO
优先权: 2001
CN
US
WO
8 件公开
Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
US 8168624 B2
申请人: AGARWAL RAJESH K
优先权: 2004
CN
EP
US
8 件公开
POLYMORPHIC FORMS OF (R)-4-(1-((3-(DIFLUOROMETHYL)-1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1-FLUOROETHYL)-N-(ISOXAZOL-3-YL)PIPERIDINE-1-CARBOXAMIDE
EP 3999504 A1
申请人: MYOKARDIA INC
优先权: 2019
CN
EP
US
WO
7 件公开
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US 6956060 B2
申请人: TECHNION RES & DEV FOUNDATION
优先权: 2001
US
6 件公开
Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-,-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
US 8084488 B2
申请人: LEONARD JASON A
优先权: 2006
US
6 件公开
第 1 / 10 页
上一页
下一页
药物
反馈